SCHEMBL3963370

SCHEMBL3963370

CCCc1ccc(C(=O)O)c(OC)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.78
PPARG P37231 1/20 0.78
ALDH1A1 P00352 3/20 0.56
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
POLB P06746 1/20 0.56
AGTR1 P30556 1/20 0.51
AGTR2 P50052 1/20 0.51
MCL1 Q07820 1/20 0.49
ALOX5 P09917 1/20 0.49
OR51E2 Q9H255 1/20 0.49
MAPK1 P28482 1/20 0.48
HTT P42858 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799996 0.90 PPARA (0.89) PPARAPPARGALDH1A1NPC1RAB9A
SCHEMBL3298521 0.88 PPARA (1.00) PPARAPPARGAGTR1AGTR2CYP1A2
SCHEMBL20504238 0.88 PPARA (1.00) PPARAPPARGAGTR1AGTR2CYP1A2
SCHEMBL31065733 0.88 PPARA (1.00) PPARAPPARGAGTR1AGTR2CYP1A2
SCHEMBL20522149 0.87 PPARG (0.60) PPARAPPARGALDH1A1NPC1RAB9A
SCHEMBL5501065 0.86 PPARG (0.68) PPARAPPARGALDH1A1SMN1; SMN2AGTR1
SCHEMBL11461004 0.85 PPARG (0.67) PPARAPPARGALDH1A1ALOX5OR51E2
SCHEMBL29196246 0.85 PPARG (0.58) PPARAPPARGALDH1A1NPC1RAB9A
SCHEMBL465065 0.85 PPARG (0.58) PPARAPPARGALDH1A1NPC1RAB9A
SCHEMBL27481259 0.85 PPARG (0.67) PPARAPPARGALDH1A1SMN1; SMN2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009042402-A2 COMPOSITION AND METHOD FOR TREATING ROSACEA LIPO CHEMICALS INC. (US) 2009-04-02 WO claimed
WO-2008073684-A1 COMPOSITION FOR TREATING AGING SKIN COMPRISING A HYDROXYCINNAMIC ACID SUCH AS P-COUMARIC ACID LIPO CHEMICALS INC. (US) 2008-06-19 WO claimed
WO-2007098022-A2 ULTRAVIOLET ABSORBER FOR COSMETICS AND POLYMERIC MATERIALS IOWA CORN PROMOTION BOARD (US) 2007-08-30 WO disclosed
US-20070189990-A1 Ultraviolet absorber for cosmetics and polymeric materials UNITED STATES DEPARTMENT OF ENERGY 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070189990-A1 Ultraviolet absorber for cosmetics and polymeric materials ADH1A, SORD, ALDOA PPARA 815/4885PPARG 1059/4885ALDH1A1 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.